The U.S. Government has a responsibility to protect the health and safety of its citizens. The American people continue to face a host of national health security threats from chemical, biological, radiological, and nuclear (CBRN) agents and emerging infectious diseases. Under the leadership of HHS, the Public Health Emergency Medical Countermeasure Enterprise (PHEMCE) is the coordinating body for the federal agencies in charge of protecting the civilian population from potential adverse health impacts through the use of medical countermeasures, which are medicines, devices, or other medical interventions that can lessen the harmful effects of these threats. The first version of the strategy and implementation plan formed by the government in 2007 provided a framework for product development successes that were made possible through funding authorized under the Project BioShield Act of 2004
. This updated Strategy and Implementation plan accounts for these gains and further expands the efforts needed to improve national capability and capacity to respond to major public health threats.
The 2012 HHS PHEMCE Strategy
articulates the strategic direction and will guide policies and decisions for the end-to-end mission of the PHEMCE. The companion 2012 HHS PHEMCE Implementation Plan
describes the activities and programs that HHS, in collaboration with its interagency partners, is undertaking over the next five years to increase MCM preparedness for national health security threats. This Strategy and the Implementation Plan together provide the blueprints the PHEMCE will follow in the near-, mid-, and long-terms to make the best use of available resources to enhance national health security.
2012 HHS PHEMCE Strategy
||Above all, the PHEMCE mission and outputs must safeguard and protect people’s lives against a wide range of hazardous threats and do so as responsible stewards of taxpayer dollars. These two core principles of the 2012 PHEMCE Strategy serve as a foundation over the next five years for the PHEMCE strategic goals:|
- Identify, create, develop, manufacture, and procure critical medical countermeasures.
- Establish and communicate clear regulatory pathways to facilitate medical countermeasure development and use.
- Develop logistics and operational plans for optimized use of medical countermeasures at all levels of response.
- Address medical countermeasure gaps for all sectors of the American civilian population.
PHEMCE Leadership has identified a set of criteria against which all investments must be prioritized. These include: (1) addressing the most significant threats, (2) fostering approaches with the potential to provide protection against multiple important threats, and (3) maintaining the capability to effectively use the assets developed. Moderating criteria include: (4) addressing the needs of all segments of the U.S. civilian population, including at-risk populations, (5) balancing rapid acquisition of current materials against significant gains in capabilities that may be possible through alternative long-term efforts, and (6) considerations of the lifecycle costs of MCMs.
2012 PHEMCE Implementation Plan
||The 2012 HHS PHEMCE Implementation Plan identifies priorities across the PHEMCE mission areas, providing:|
This document constitutes the blueprint the PHEMCE will follow in the near-, mid-, and long-terms to enhance national health security while making the best use of available resources.
- a high-level description of programs and initiatives that support the goals and objectives laid out in the Strategy;;
- an overview of PHEMCE interagency partner roles and collaborations;
- a detailed description of threat-specific approaches;
- a description of specific capability-based approaches; and
- a summary of key milestones to track progress over the next five years.
This document constitutes the blueprint the PHEMCE will follow in the near-, mid-, and long-terms to enhance national health security while making the best use of available resources
2007 HHS PHEMCE Strategy and Implementation Plan
The 2007 HHS PHEMCE Strategy and Implementation Plan for Chemical, Biological, Radiological, and Nuclear Threats predominantly focused on advanced development and acquisition priorities for medical countermeasures using funds available in the Special Reserve Fund authorized under the Project BioShield Act of 2004.
2007 HHS PHEMCE Strategy
The HHS PHEMCE Strategy established the goals and objectives that HHS used to ensure that medical countermeasures are available for effective use against the highest priority CBRN threats facing the Nation.
2007 HHS PHEMCE Implementation Plan
The HHS PHEMCE Implementation Plan is a prioritized plan with near-term (FY07-08), mid-term (FY09-13) and long-term (FY14-23) goals for research, development, and acquisition of medical countermeasures.